Understanding Key Drivers and Growth Opportunities in the RNA Targeting Small Molecule Drug Discovery Market: Trends and Market Size Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Major Innovations Are Driving the Accelerated Growth of the RNA Targeting Small Molecule Drug Discovery Market?
The upward trend in the incidence of cancer, genetic abnormalities, and viral illnesses is anticipated to catalyze the expansion of the RNA-targeted small-molecule drug discovery market. Cancer consists of a variety of diseases typified by the uncontrolled proliferation of body cells. Viral infections are illnesses instigated by viruses, minuscule invasive entities that can only multiply within the cells of living beings. Drug discovery based on RNA targeting is utilized to combat cancer, genetic maladies, and viral infections, as these afflictions are associated with genes and defective genetic material. These conditions can be treated with medications created via RNA targeting techniques. For example, the World Health Organization (WHO), a Switzerland-based global body, issued a report in February 2024 stating that there were approximately 20 million new cancer cases and 9.7 million fatalities worldwide in 2022. Lung cancer held the highest percentage at 12.4% with 2.5 million new cases, followed by breast cancer in women (2.3 million cases, 11.6%), colorectal cancer (1.9 million cases, 9.6%), prostate cancer (1.5 million cases, 7.3%), and stomach cancer (970,000 cases, 4.9%). By 2050, there is an anticipated 77% increase in new cancer cases, surpassing 35 million annually. Consequently, the escalating incidence of cancer, genetic anomalies, and viral infections bolsters the RNA-targeted small-molecule drug discovery market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12480&type=smp
How Has the RNA Targeting Small Molecule Drug Discovery Market Evolved in Recent Years, and What are the Growth Projections for the Forecast Period?
The market size for RNA targeting small molecule drug discovery has notably expanded in the latest years. Its growth is expected to surge from $1.76 billion in 2024 to $2.14 billion in 2025, showing a compound annual growth rate (CAGR) of 21.8%. Factors fueling this growth during the historic period include an enhanced comprehension of disease genetics, breakthroughs in genomic and proteomic research, the issue of drug resistance, investment in biotech and pharmaceutical research, and the emergence of RNA therapeutics.
There is an anticipation for the RNA targeting small molecule drug discovery market to witness a massive increase in value in the forthcoming years. At a compound annual growth rate (CAGR) of 23.1%, its market size is projected to reach $4.92 billion by 2029. The expected surge during the forecast period is linked to the growth in areas such as RNA epigenetics research, RNA-seq and functional genomics, integration of artificial intelligence (AI), patient-oriented strategies, and exosome-mediated drug delivery. Future trends during this period consist of the rise of RNA editing technologies, progress in CRISPR technology, technological innovations, advancements in the field of RNA biology, and the use of RNA targeting for neurodegenerative diseases.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12480
What Are the Most Significant Market Trends Transforming theRNA Targeting Small Molecule Drug Discovery Market?
The trend of incorporating artificial intelligence (AI) into drug discovery processes is catching on in the small-molecule drug discovery market. To maintain their market status, leading businesses in the small molecule drug discovery realm are capitalizing on AI advancements for propelling the rate of drug discovery. As an illustration, Google Cloud, a wing of US tech firm Google launched the Target and Lead Identification Suite and Multiomics Suite in May 2023, to aid the drug discovery course. The role of the Multiomics Suite is to speed up genetic data identification and analysis, helping companies to craft precision medicines. The Target and Lead Identification Suite offers researchers assistance in comprehending the function of amino acids and predicting protein structure.
What Are the Top Market Players Propelling the Growth of theRNA Targeting Small Molecule Drug Discovery Industry?
Major companies operating in the RNA targeting small molecule drug discovery market include F. Hoffmann-La Roche Ltd, Merck & Co. Inc, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Moderna Inc., Astellas Pharma Inc., Biogen Inc., Alnylam Pharmaceuticals Inc., Sarepta Therapeutics Inc., Evotec A.G., PTC Therapeutics Inc., Ionis Pharmaceuticals Inc., Dicerna Pharmaceuticals Inc., Arrakis Therapeutics, Arbutus Biopharma Corporation, H3 Biomedicine Inc., Anima Biotech Inc., Ribometrix Inc., Quark Pharmaceuticals Inc., Regulus Therapeutics Inc., Skyhawk Therapeutics Inc., Accent Therapeutics Inc., Epics Therapeutics, Expansion Therapeutics
Order Your Report Now For A Swift Delivery:
Which Primary Segments of the RNA Targeting Small Molecule Drug Discovery Market Are Driving Growth and Industry Transformations?
The RNA targeting small molecule drug discovery market covered in this report is segmented –
1) By Target RNA Type: Messenger RNA (mRNA), Non-Coding RNA (ncRNA), MicroRNA (miRNA), Long Non-Coding RNA (lncRNA)
2) By Technology: CRISPR-Cas9, RNA Aptamers, Small Interfering RNA (siRNA), Ribozymes, Other Technologies
3) By Therapeutic Area: Oncology, Neurology, Infectious Disease, Metabolic Diseases, Genetic Disorders, Other Therapeutic Areas
4) By Delivery Method: Intravenous (IV), Oral, Topical, Other Methods
5) By Application: Research Use, Therapeutic Use, Diagnostic Use, Other Applications
Subsegments:
1) By Messenger RNA (mRNA): Targeting mRNA For Protein Coding, Modulation Of mRNA Stability, mRNA Translation Inhibition
2) By Non-Coding RNA (ncRNA): Long Non-Coding RNA, Small Nuclear RNA, Small Nucleolar RNA
3) By MicroRNA (miRNA): miRNA Inhibition, miRNA Mimics, Targeting Specific miRNA Pathways
4) By Long Non-Coding RNA (lncRNA): lncRNA Modulators, Targeting Specific lncRNA Functions, Therapeutic Applications Of lncRNA
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=12480&type=smp
Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the RNA Targeting Small Molecule Drug Discovery Market?# Market?
North America was the largest region in the RNA-targeting small molecule drug discovery market in 2024. The regions covered in the RNA targeting small molecule drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Reports Similar to the Gobal RNA Targeting Small Molecule Drug Discovery Maret 2025, By The Business Research Company:
Drug Discovery Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-discovery-services-global-market-report
Drug Discovery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/drug-discovery-global-market-report
Small Molecule Drug Discovery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
